01353nam 2200373Ia 450 991069935280332120230902161950.0(CKB)5470000002402388(OCoLC)502243286(EXLCZ)99547000000240238820100128d1999 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] qualifying for pediatric exclusivity under section 505A of the Federal Food, Drug, and Cosmetic ActRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :Center for Biologics Evaluation and Research,[1999]1 online resource (ii, 22 pages)"Procedural.""Revised, September 1999."Guidance for industry PediatricsUnited StatesDrug approvalUnited StatesPediatricsDrug approvalCenter for Drug Evaluation and Research (U.S.)Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910699352803321Guidance for industry3434577UNINA